U.S. Pharma Stock News

Context for Aflac’s Recent Share Performance Aflac (AFL) has seen a 0.8% decline over the past day and a 2.3% decline over the past week, with the share price now at $108.71 as investors reassess recent returns. See our latest analysis for Aflac. While the 1 month share price return of 6.5% and year to date share price return of 1.4% are both negative, Aflac’s 1 year total shareholder return of 3.6% and 5 year total shareholder return of 138.3% point to momentum that has built over a longer...

Albany International (NYSE:AIN) has been named an official partner for World Engineering Day for Sustainable Development 2026. The partnership spotlights the company’s role in materials science for sustainability and raises its profile with global engineering and policy audiences. For investors watching Albany International at a share price of $53.57, this new partnership adds a fresh layer of visibility that does not show up directly in recent price moves. The stock has seen a 26.3%...

If you are wondering whether Bentley Systems is currently priced attractively or if the share price already reflects its quality, this article explains what the current valuation suggests. The stock last closed at US$38.19, with recent returns showing a 4.0% decline over 7 days, a 12.6% gain over 30 days, and results that are roughly flat year to date and lower over 1 and 3 years. Recent coverage has focused on how investors are reassessing software names as interest rates, infrastructure...

Why Western Alliance Bancorporation Is On Investors’ Radar Western Alliance Bancorporation (WAL) is back in focus after a stretch of weaker share performance, with the stock showing declines over the past week, month, past 3 months, year to date, and past year. See our latest analysis for Western Alliance Bancorporation. With the share price recently at US$67.97 and a 30 day share price return showing a 28.32% decline, short term momentum has faded. However, the 3 year total shareholder...

Levi Strauss (NYSE:LEVI) has launched new global brand campaigns featuring ambassadors such as Alia Bhatt in India and Charlotte Cardin in France, with a focus on key international markets and the women's segment. The company has entered a global e commerce partnership with SCAYLE to upgrade the levi.com experience across the U.S., Canada, and Europe. Levi Strauss is expanding its STITCH AI tool for store employees and planning additional AI driven features for customers and teams. Levi...

If you are wondering whether DICK'S Sporting Goods is reasonably priced or getting ahead of itself, this article will walk through how its current share price stacks up against several valuation checks. The stock last closed at US$192.16, with returns of 1.1% over the past year, 42.0% over 3 years and 175.9% over 5 years. Shorter term moves have been softer, with a 2.6% decline over 7 days, 6.0% decline over 30 days and 4.0% decline year to date. Recent attention on DICK'S Sporting Goods has...

In recent days, Raymond James reiterated its Market Perform rating on WEX after a fireside chat at its 47th annual Institutional Investors Conference, while Clifford Capital Partners disclosed a new US$14.00 million position following WEX’s 2025 record revenue of US$2.70 billions. Together, the analyst’s increased confidence in WEX’s growth framework and the fresh institutional stake highlight how management engagement and benefits/corporate payments strength are shaping institutional...

Intapp (INTA) is back on investor radars after Omnes Capital, a European private equity firm focused on the energy transition, selected Intapp’s DealCloud platform for marketing and investor relations workflows. See our latest analysis for Intapp. The Omnes Capital win comes after a volatile stretch for Intapp’s stock. A 1 day share price return of 4.06% has taken the latest share price to $25.65. However, a 90 day share price return of 40.32% and 1 year total shareholder return of 56.73%...

If you are wondering whether W. R. Berkley is fairly priced or offering value right now, the starting point is to look closely at what the current share price actually reflects. The stock most recently closed at US$68.76, with returns of a 1.7% decline over 7 days, a 3.9% decline over 30 days, a 0.9% decline year to date, 11.7% over 1 year, 81.7% over 3 years and 135.1% over 5 years. This gives you a mix of short term weakness and longer term strength to weigh up. Recent news around W. R...

Mercury Systems (NasdaqGS:MRCY) has acquired SolderMask, Inc., adding specialized manufacturing capabilities and intellectual property. The deal brings in skilled personnel and assets that directly support more than 20 active Mercury programs tied to critical defense work. The acquisition is intended to accelerate production efficiency and strengthen delivery commitments across key customer contracts. Mercury Systems, trading at $78.16, has seen a 68.0% return over the past year and a 69.1%...

Kymera Therapeutics recently advanced its first IRF5-directed oral therapy, KT-579, into human clinical testing and reported Phase 1b data for its oral STAT6 degrader KT-621, which appeared comparable or better than injectable dupilumab in a large inflammatory disease market. This progress positions Kymera as a pioneer in oral protein degraders that aim to match biologic-like efficacy while potentially offering more convenient, small-molecule treatment options. We’ll now examine how Kymera’s...

If you are wondering whether Tetra Tech shares are offering fair value right now, this article walks through what the current price could mean for long term investors. The stock last closed at US$32.18, with a 7.7% decline over the past week, a 20.4% decline over the past month, and returns of 11.3% over 1 year, 17.9% over 3 years, and 28.8% over 5 years. Recent coverage has focused on Tetra Tech as a US listed commercial services company and on how its current share price compares with...

Madrigal Pharmaceuticals recently reported that its MASH drug Rezdiffra generated nearly US$1.00 billion in its first full year on the market, reinforcing the company’s leading position in this disease area. This rapid commercial traction, coupled with management’s expectation for continued robust net sales growth in 2026, has attracted heightened attention from both institutional investors and short-sellers. Next, we’ll examine how Rezdiffra’s nearly US$1.00 billion first-year sales...

If you are wondering whether Piper Sandler Companies' current share price really reflects its underlying worth, or if the recent run leaves room for value, this article walks through that question step by step. The stock last closed at US$282.30, with returns showing a 3.8% decline over 7 days, a 17.4% decline over 30 days, a 19.3% decline year to date, a 14.2% gain over 1 year and a very large 3 year and 5 year return. Recent coverage around Piper Sandler Companies has focused on its role...

Unity Software (NYSE:U) has seen significant insider selling activity while reporting expanding operating margins. At the same time, the company is working through revenue growth challenges that have drawn fresh attention from investors. The mix of insider sales, margin improvement, and pressure on growth is raising new questions about Unity's internal outlook and business direction. For investors watching Unity Software at a share price of $19.43, the recent pattern of insider selling...

In early March 2026, LifeMD, Inc. reported that it moved from a US$21.41 million annual net loss in 2024 to US$14.35 million net income in 2025, issued double‑digit revenue growth guidance for 2026, and highlighted expanding telehealth offerings including its oral Wegovy weight management launch with Novo Nordisk. This shift to profitability, combined with more than 322,000 active subscribers and growing GLP‑1 and women’s health programs, signals a business model that is scaling across...

If you are wondering whether NetApp's share price really reflects what the business is worth today, you are not alone. That is exactly what this article will unpack. NetApp shares last closed at US$98.66, with returns of 9.5% over 1 year, 71.3% over 3 years and 58.3% over 5 years. However, the stock has seen a 2.4% decline over 7 days, 6.8% over 30 days and 7.3% year to date. Recent company specific headlines have continued to keep investor attention on NetApp, helping frame how the market...

PGIM, the global investment management arm of Prudential Financial (NYSE:PRU), received multiple 2026 LSEG Lipper Fund Awards. The awards recognize consistent, risk adjusted performance across PGIM funds. The recognition extends Prudential Financial's record of industry accolades for its asset management platform. For a company often associated first with insurance and annuities, these LSEG Lipper Fund Awards put a spotlight on a different side of Prudential Financial: its global asset...

WM Technology (MAPS) closed out FY 2025 with Q4 revenue of about US$43.1 million and a basic EPS loss of roughly US$0.03, while trailing twelve month EPS stood at around US$0.02 on revenue of roughly US$174.7 million. Over recent periods the company has seen quarterly revenue range between about US$42.2 million and US$47.7 million, with EPS moving from a profit of roughly US$0.03 per share in late 2024 to small profits through most of 2025 before the latest quarterly loss. This has left...

If you are wondering whether Moelis shares offer good value at today's price, it helps to step back and look at what the current market is implying about the business. The stock last closed at US$51.75, after a 7.8% decline over the past week, a 25.1% decline over the past month, and a 27.3% decline year to date, while still showing a 51.6% return over 3 years and 23.6% over 5 years. These recent moves have kept Moelis on investors' radars, with market commentary often linking advisory firms...

Why Utz Brands Stock Is On Investors’ Radar Utz Brands (UTZ) has drawn fresh attention after a sharp share price pullback, with the stock around $7.56 and showing negative returns over the past month and past 3 months. See our latest analysis for Utz Brands. The recent pullback has been steep, with a 30 day share price return of a 32.08% decline and a 90 day share price return of a 26.10% decline. Over the longer term, the 1 year total shareholder return of a 41.97% decline points to...

Immunic, Inc. recently secured a key European patent for its lead asset vidofludimus calcium, aligning protection with existing U.S. coverage and potentially extending exclusivity into the 2040s for chronic inflammatory and autoimmune indications. This expanded intellectual property protection materially underpins the company’s core therapeutic franchise by lengthening its runway to develop and, if approved, commercialize its main clinical asset. Against this backdrop, we’ll explore how the...

If you are wondering whether Futu Holdings is attractively priced or getting ahead of itself, this article will walk through what the current share price might be implying about its value. The stock last closed at US$141.14, with returns of 19.1% over 1 year and a very large 3 year gain. However, the year to date return sits at a 20.9% decline and the 30 day return at an 8.8% decline. Recent coverage has focused on Futu Holdings as a major online brokerage name listed on the Nasdaq, with...

Precision BioSciences (DTIL) closed out FY 2025 with Q4 revenue of US$34.2 million and Basic EPS of US$1.01, alongside earnings from discontinued operations of US$0.9 million and net income excluding extra items of US$19.2 million. Over recent quarters, the company has seen revenue range from US$0.6 million in Q4 2024 to US$34.2 million in Q4 2025. Over the same period, quarterly Basic EPS has moved from a loss of US$2.22 in Q4 2024 to a profit of US$1.01 in Q4 2025. This sets up an earnings...